Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Nicola Principi, Laura Senatore & Susanna Esposito. (2015) Protection of young children from influenza through universal vaccination. Human Vaccines & Immunotherapeutics 11:10, pages 2350-2358.
Read now
Read now
Adrian Reber & Jacqueline Katz. (2013) Immunological assessment of influenza vaccines and immune correlates of protection. Expert Review of Vaccines 12:5, pages 519-536.
Read now
Read now
Nicola Principi & Susanna Esposito. (2012) Adjuvanted influenza vaccines. Human Vaccines & Immunotherapeutics 8:1, pages 59-66.
Read now
Read now
Emanuele Montomoli, Simona Piccirella, Baharak Khadang, Elisa Mennitto, Roberto Camerini & Alfonso De Rosa. (2011) Current adjuvants and new perspectives in vaccine formulation. Expert Review of Vaccines 10:7, pages 1053-1061.
Read now
Read now
Nicola Principi, Susanna Esposito & Paola Marchisio. (2011) Present and future of influenza prevention in pediatrics. Expert Opinion on Biological Therapy 11:5, pages 641-653.
Read now
Read now
Christian Moser, Mario Amacker & Rinaldo Zurbriggen. (2011) Influenza virosomes as a vaccine adjuvant and carrier system. Expert Review of Vaccines 10:4, pages 437-446.
Read now
Read now
Malou Henriksen-Lacey, Karen Smith Korsholm, Peter Andersen, Yvonne Perrie & Dennis Christensen. (2011) Liposomal vaccine delivery systems. Expert Opinion on Drug Delivery 8:4, pages 505-519.
Read now
Read now
Articles from other publishers (11)
Kellie D. Nance & Jordan L. Meier. (2021) Modifications in an Emergency: The Role of N1-Methylpseudouridine in COVID-19 Vaccines. ACS Central Science 7:5, pages 748-756.
Crossref
Crossref
Young Hun Chung, Veronique Beiss, Steven N. Fiering & Nicole F. Steinmetz. (2020) COVID-19 Vaccine Frontrunners and Their Nanotechnology Design. ACS Nano 14:10, pages 12522-12537.
Crossref
Crossref
Yvonne Perrie, Fraser Crofts, Andrew Devitt, Helen R. Griffiths, Elisabeth Kastner & Vinod Nadella. (2016) Designing liposomal adjuvants for the next generation of vaccines. Advanced Drug Delivery Reviews 99, pages 85-96.
Crossref
Crossref
Heng Liu, Jacqueline de Vries-Idema, Wouter ter Veer, Jan Wilschut & Anke Huckriede. (2013) Influenza virosomes supplemented with GPI-0100 adjuvant: a potent vaccine formulation for antigen dose sparing. Medical Microbiology and Immunology 203:1, pages 47-55.
Crossref
Crossref
Christian Moser & Mario Amacker. 2013. Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines. Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines
287
307
.
Malou Henriksen-Lacey & Yvonne Perrie. 2013. Immunomic Discovery of Adjuvants and Candidate Subunit Vaccines. Immunomic Discovery of Adjuvants and Candidate Subunit Vaccines
181
203
.
Ashwini Kumar Giddam, Mehfuz Zaman, Mariusz Skwarczynski & Istvan Toth. (2012) Liposome-based delivery system for vaccine candidates: constructing an effective formulation. Nanomedicine 7:12, pages 1877-1893.
Crossref
Crossref
Jessica C. Seidman, Stephanie A. Richard, Cécile Viboud & Mark A. Miller. (2011) Quantitative review of antibody response to inactivated seasonal influenza vaccines. Influenza and Other Respiratory Viruses 6:1, pages 52-62.
Crossref
Crossref
Susanna Esposito & Nicola Principi. (2011) Different influenza vaccine formulations and adjuvants for childhood influenza vaccination. Vaccine 29:43, pages 7535-7541.
Crossref
Crossref
Terho Heikkinen & Santtu Heinonen. (2011) Effectiveness and safety of influenza vaccination in children: European perspective. Vaccine 29:43, pages 7529-7534.
Crossref
Crossref
T. Jelinek. (2010) Impfprävention bei chronischen ErkrankungenVaccination of patients with chronic diseases. Prävention und Gesundheitsförderung 5:S1, pages 5-9.
Crossref
Crossref